Unknown

Dataset Information

High Somatic Mutation and Neoantigen Burden Do Not Correlate with Decreased Progression-Free Survival in HCC Patients not Undergoing Immunotherapy.


ABSTRACT: Cancer genome instability leads to accumulation of mutations which may result into tumor-specific mutated "neoantigens", not be affected by central T-cell tolerance. Such neoantigens are considered the optimal target for the patient's anti-tumor T cell immunity as well as for personalized cancer immunotherapy strategies. However, only a minor fraction of predicted neoantigens are relevant to the clinical outcome. In the present study, a prediction algorithm was applied using datasets of RNA sequencing from all 377 Hepatocellular carcinoma (HCC) patients available at The Cancer Genome Atlas (TCGA), to predict neoantigens to be presented by each patient's autologous HLA molecules. Correlation with patients' survival was performed on the 115 samples for whom the exact date of death was known.

SUBMITTER: Mauriello A 

PROVIDER: S-EPMC6966682 | biostudies-literature | 2019 Nov

REPOSITORIES: biostudies-literature